The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Effect of Fenoldopam on Use of Renal Replacement Therapy Among Patients With Acute Kidney Injury After Cardiac Surgery: A Randomized Clinical Trial
Abstract
IMPORTANCE: No effective pharmaceutical agents have yet been identified to treat acute kidney injury after cardiac surgery. OBJECTIVE: To determine whether fenoldopam reduces the need for renal replacement therapy in critically ill cardiac surgery patients with acute kidney injury. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, randomized, double-blind, placebo-controlled, parallel-group study from March 2008 to April 2013 in 19 cardiovascular intensive care units in Italy. We randomly assigned 667 patients admitted to intensive care units after cardiac surgery with early acute kidney injury (≥50% increase of serum creatinine level from baseline or oliguria for ≥6 hours) to receive fenoldopam (338 patients) or placebo (329 patients). We used a computer-generated permuted block randomization sequence for treatment allocation. All patients completed their follow-up 30 days after surgery, and data were analyzed according to the intention-to-treat principle. INTERVENTIONS: Continuous infusion of fenoldopam or placebo for up to 4 days with a starting dose of 0.1 μg/kg/min (range, 0.025-0.3 µg/kg/min). MAIN OUTCOMES AND MEASURES: The primary end point was the rate of renal replacement therapy. Secondary end points included mortality (intensive care unit and 30-day mortality) and the rate of hypotension during study drug infusion. RESULTS: The study was stopped for futility as recommended by the safety committee after a planned interim analysis. Sixty-nine of 338 patients (20%) allocated to the fenoldopam group and 60 of 329 patients (18%) allocated to the placebo group received renal replacement therapy (P = .47). Mortality at 30 days was 78 of 338 (23%) in the fenoldopam group and 74 of 329 (22%) in the placebo group (P = .86). Hypotension occurred in 85 (26%) patients in the fenoldopam group and in 49 (15%) patients in the placebo group (P = .001). CONCLUSIONS AND RELEVANCE: Among patients with acute kidney injury after cardiac surgery, fenoldopam infusion, compared with placebo, did not reduce the need for renal replacement therapy or risk of 30-day mortality but was associated with an increased rate of hypotension. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00621790.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Cited by
Meersch, M., Schmidt, C., Hoffmeier, A., Van Aken, H., Wempe, C., Gerss, J., & Zarbock, A. (2017) · Intensive Care Medicine · doi:10.1007/s00134-016-4670-3 · Cited by 892
Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment
Wang, Y., & Bellomo, R. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.119 · Cited by 767
Self-citationAcute kidney injury following cardiac surgery: current understanding and future directions
O’Neal, J. B., Shaw, A. D., & Billings, F. T. (2016) · Critical Care · doi:10.1186/s13054-016-1352-z · Cited by 553
Grams, M. E., Sang, Y., Coresh, J., Ballew, S., Matsushita, K., Molnar, M. Z., Szabo, Z., Kalantar-Zadeh, K., & Kovesdy, C. P. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.07.022 · Cited by 348
Joannidis, M., Druml, W., Forni, L. G., Groeneveld, A. B. J., Honore, P. M., Hoste, E., Ostermann, M., Oudemans-van Straaten, H. M., & Schetz, M. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4832-y · Cited by 340
Metadata
- Authors
- Bove, T., Zangrillo, A., Guarracino, F., Alvaro, G., Persi, B., Maglioni, E., Galdieri, N., Comis, M., Caramelli, F., Pasero, D. C., Pala, G., Renzini, M., Conte, M., Paternoster, G., Martinez, B., Pinelli, F., Frontini, M., Zucchetti, M. C., Pappalardo, F., Amantea, B., Camata, A., Pisano, A., Verdecchia, C., Dal Checco, E., Cariello, C., Faita, L., Baldassarri, R., Scandroglio, A. M., Saleh, O., Lembo, R., Calabrò, M. G., Bellomo, R., & Landoni, G.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2014-12-03
- Volume
- 312
- Issue
- 21
- Pages
- 2244
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2008233785
- Cited by
- 181
- References
- 1
- FWCI
- 16.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Fenoldopam on Use of Renal Replacement Therapy Among Patients With Acute Kidney Injury After Cardiac Surgery: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2014.13573
- The paper
- Bove, T., Zangrillo, A., Guarracino, F., Alvaro, G., Persi, B., Maglioni, E., Galdieri, N., Comis, M., Caramelli, F., Pasero, D. C., Pala, G., Renzini, M., Conte, M., Paternoster, G., Martinez, B., Pinelli, F., Frontini, M., Zucchetti, M. C., Pappalardo, F., . . . Landoni, G. (2014). Effect of Fenoldopam on Use of Renal Replacement Therapy Among Patients With Acute Kidney Injury After Cardiac Surgery: A Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2014.13573
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.